C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/18 (2006.01) A61K 39/42 (2006.01) C07K 14/135 (2006.01) C07K 16/10 (2006.01) G01N 33/569 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2167835
The present invention relates to antibodies directed against Respiratory Syncytial Virus (RSV), and hybridoma lines which produce them (e.g., HNK20). The antibodies can be used for the prevention or treatment of RSV infection and disease, as well as employed in methods for diagnosing RSV infection.
Cette invention concerne des anticorps dirigés contre le virus respiratoire syncytial (RSV) et des lignées cellulaires d'hybridomes qui les produisent (HNK20 par exemple). Ces anticorps peuvent être utilisés pour prévenir ou traiter l'infection à RSV et la maladie associée, et dans des procédés de diagnostic de l'infection à RSV.
Oravax Inc.
Smart & Biggar
LandOfFree
Monoclonal iga antibody against respiratory syncytial virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal iga antibody against respiratory syncytial virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal iga antibody against respiratory syncytial virus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1915960